Home > Riviste > Minerva Chirurgica > Fascicoli precedenti > Minerva Chirurgica 2017 June;72(3) > Minerva Chirurgica 2017 June;72(3):237-47

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA CHIRURGICA

Rivista di Chirurgia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,115


eTOC

 

REVIEW  


Minerva Chirurgica 2017 June;72(3):237-47

DOI: 10.23736/S0026-4733.17.07350-3

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of minimally invasive surgery in neuroendocrine pancreatic tumors

Eugenia YIANNAKOPOULOU

Department of Medical Laboratories, Faculty of Health and Caring Professions, Highest Technological Educational Institute of Athens, Athens, Greece


PDF  


Minimally invasive surgery has an established role in the treatment of patients with pancreatic neuroendocrine tumors (pNETs). Enucleation is an established treatment option for insulinomas. The necessity of organ sparing surgery is well established in the case of multiple pNETs. A number of studies have demonstrated the efficacy and safety of laparoscopic surgery for the treatment of pNETs. However, pNETs are rare, and large studies focusing on pNET patients are difficult to be designed unless multicenter experience is collected. Authors investigating the role of minimally invasive pancreatic surgery should be encouraged to report separately the results that involve patients presenting with pNETs. A European registry of patients with pNETs treated with minimally invasive surgery would allow further investigation of the optimal treatment of these patients. Especially in the case of syndromic pNETs, that are rare entities, co-operation and exchange of information is needed among different centers for sharing experience and transferring knowledge. Existing data come from small cohort studies, case series and case reports. Given that, pancreatic surgery is especially demanding advanced surgery with training that is not yet standardized, further research is needed for defining its role in the treatment of pancreatic neuroendocrine tumors. Regarding the role of robot-assisted surgery in the treatment of pNETS, data are quite scarce.


KEY WORDS: Neuroendocrine tumors - Pancreas - Minimally invasive surgical procedures - Insulinoma - Laparoscopy - Pancreatectomy

inizio pagina

Publication History

Issue published online: May 4, 2017
Article first published online: March 27, 2017

Per citare questo articolo

Yiannakopoulou E. The role of minimally invasive surgery in neuroendocrine pancreatic tumors. Minerva Chir 2017;72:237-47. DOI: 10.23736/S0026-4733.17.07350-3

Corresponding author e-mail

nyiannak@teiath.gr